bepatient and Digitsole, strategic partnership to improve direct-to-patient data capture solutions

French smart-footwear MedTech start-up Digitsole and Digital Therapeutics platform bepatient are pleased to announce their strategic collaboration.

Podosmart

When your mobility watches
for your health daily!

Patient engagement
for data intelligence

Paris, France, May 11, 2021 – bepatient, a French pioneer in the development of Virtual Trial and Digital Therapeutics Solutions and and Digitsole, a smart-footwear MedTech start-up, have announced their partnership in the development of integrated direct-to-patient data capture solutions to address both Clinical Research and Digital Therapeutics environments. The solution will be marketed to Pharma, Medical Devices and Biotech companies, as well as Contract Research Organizations (CROs).

Digitsole is operating in eHealth and well-being.

Digitsoles vision is that seamless mobility assessment will transform daily personal health monitoring and evolve towards predictive medicine. Digitsole’s easy-to-use smart connected sole enables to empower patients and enrich the Health Care Professional (HCP) diagnosis and follow up. 

With its strong entrepreneurial culture, bepatient has been developing since 2011 a proprietary eHealth platform, enabling to build direct-to-patient data collection solutions for Virtual Clinical Trials as well as patient Companion Apps, linked to intuitive monitoring interfaces for HCPs.

Digitsole and bepatient are both specialists in the collection and management of value-added Real World Evidence data.

« We observe a growing interest in biomechanical mobility data capture in Clinical Research and Digital Therapeutics segments, with potential application in many therapeutic areas (inflammatory diseases, chronic pain, rheumatology, oncology, cardiometabolic…). This collaboration will allow us to address new needs, but also to improve our existing solutions. »

Frederic Durand Salmon - bepatient CEO

« We are extremely pleased to announce our fruitful cooperation with bepatient. Both companies are experts in gathering, analysing and sharing real world data for patients’ benefit. Together we provide an integrated solution combining data generated for virtual trials and patients’ mobility data. Such data will speed up and enhance virtual trials, while increasing the value of the real world evidence. Overall we will will work together to optimize health and improve our algorithms and therefore our solutions. »

Fabrice Rosenstiehl - COO & CMO of Digitsole

About Digitsole

Digitsole is smartfootwear Medtech, operating in eHealth and well-being. We are a French start-up bringing together data – digital biomarkers, biomechanical and clinical expertise to improve the well-being of people through their lives. We are fast-growing and have traction with customers in more than 37 countries already.

While our core applications deliver value to the healthcare mobility specialists– podiatrists, physios, chiropractors, orthopedic – our influence and potential goes beyond: we believe that real-world information can lead to patients, athletes, employees and everyone staying healthier.

About bepatient

Bepatient is a French start-up that has been developing since 2011 a comprehensive and modular core platform, enabling patients to be connected at home to Healthcare Professionals and to generate value-added Real-World Evidence (RWE) data. The bepatient portfolio of solutions is structured around two activities: Clinical Research digitalization via direct-to-patient virtual trials technologies (ePRO, eCOA, eConsent, integration of connected devices, eCRF, etc.) and Digital Therapeutics: evidence-based Companion Apps integrating symptom checking, management of treatment adherence, remote monitoring, eLearning…
Bepatients activities are mainly concentrated in Europe, with a wide range of therapeutic areas such as cardiology, inflammatory diseases, oncology, metabolic diseases and chronic pain.

Press contact

You are a media and you wish to contact us? Leave us a message and we will answer you as soon as possible.